For example, in a mouse model of MLL-AF4 rearranged infant ALL, bromodomain inhibition decreased leukemic cell engraftment in vivo and increased sensitivity to glucocorticoid therapy. The gene discussed is KMT2A; the disease is acute lymphoblastic leukemia.